+36.1%
MRNA vs FND
-50.3%
+86.4%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FND | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.0% | +4.4% | +4.9% |
| 7D | -1.1% | -5.8% | +4.7% | +1.8% |
| 30D | +126.1% | -20.2% | +146.3% | +153.3% |
| 3M | +190.0% | -12.0% | +202.0% | +208.4% |
| 6M | +157.2% | -18.5% | +175.7% | +180.5% |
| YTD | +388.2% | -22.3% | +410.5% | +437.5% |
| 1Y | +467.0% | -47.6% | +514.7% | +644.4% |
| 3Y | +36.1% | -49.8% | +85.8% | +70.9% |
| All | +36.1% | -50.3% | +86.4% | +70.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FND.
Daily Out/Under-Performance
Portfolio return minus FND return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FND return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FND wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling